Table 1.
Weighted averages of HIV drug resistance EWI performance from 35 HIV care and treatment facilities, aggregated by programmatic characteristics, Tanzania, 2010
|
Programmatic characteristics |
HIVDR early warning indicators (EWIs) |
|||||
|---|---|---|---|---|---|---|
| |
|
|
EWI 1a, ART prescription practices |
EWI 2, patients LTFU at 12 months |
EWI 3a, retention on 1st line ART at 12 months |
EWI 5b, clinic appointment keeping in first 12 months |
| |
|
|
WHO target: 100% |
WHO target: ≤ 20% |
WHO target: ≥ 70% |
WHO target: ≥ 80% |
| Facility counts n (%) | Total # initiated on ART in 2010 | % | % (95% CI) | % (95% CI) | % (95% CI) | |
|
National average performance on EWIs |
35 (100) |
13,466 |
100 |
26 (25–26) |
54 (53–54) |
38 (37–38) |
|
Facility administrative level | ||||||
| Referral hospitals |
4 (11) |
2346 |
100 |
25 (24–26) |
53 (52–55) |
54 (53–55) |
| Non-referral hospitals |
17 (49) |
8512 |
100 |
22 (21–23) |
56 (55–56) |
37 (36–37) |
| Health centers |
14 (40) |
2608 |
100 |
32 (30–33) |
51 (49–52) |
31 (30–32) |
|
Facility geographical locality | ||||||
| Urban |
20 (57) |
11,604 |
100 |
22 (22–23) |
56 (55–56) |
40 (40–41) |
| Semi-urban |
6 (17) |
601 |
100 |
43 (41–46) |
39 (37–41) |
29 (28–30) |
| Rural |
9 (26) |
1261 |
100 |
27 (26–28) |
55 (54–56) |
33 (32–34) |
|
Facility ownership | ||||||
| Public |
28 (80) |
9661 |
100 |
24 (23–25) |
54 (53–55) |
34 (33–34) |
| Faith-based |
7 (20) |
3805 |
100 |
30 (29–31) |
53 (52–54) |
50 (49–51) |
|
Facility maturity (years providing ART services) | ||||||
| > 5 |
6 (17) |
4684 |
100 |
18 (17–19) |
61 (60–62) |
47 (46–48) |
| 3-5 |
15 (43) |
6174 |
100 |
25 (24–26) |
52 (51–53) |
37 (37–38) |
| < 3 |
14 (40) |
2608 |
100 |
32 (30–33) |
51 (49–52) |
31 (30–32) |
| Median: 4 years IQR: 2–5 years | ||||||
IQR interquartile range.
EWI 1a, % of adult patients initiating ART at the site who are initially prescribed, or who initially pick up from the pharmacy, an appropriate first-line ART regimen.
EWI 2, % of patients initiating ART at the site who are lost to follow-up (LTFU) 12 months after ART initiation.
EWI 3a, % of adult patients initiating ART at the site who are taking an appropriate first-line ART regimen 12 months later.
EWI 5b, % of patients initiating ART at the site who attended all scheduled or expected clinical consultations on time during the first 12 months.